Scientific Programme Thursday, 17 June 2021 Joint Sessions, Virtual Room 1 08:30 - 09:30 Joint SSP-EFP Session COVID-19 Chair: Michael Tamm (Basel, Switzerland) Chair: Zouhair Souissi (Tunis, Tunisia) 08:30 - 08:40 Short 2021 update on treatment options in COVID19 Alexandra Calmy (Geneva, Switzerland) 08:40 - 08:50 COVID in children: (including multisystem inflammatory syndrome) Arnaud L’Huillier (Geneva, Switzerland) 08:50 - 09:00 Acute respiratory failure in COVID patients outside the ICU Dan Adler (Geneva, Switzerland) 09:00 - 09:10 COVID and vascular disease (vasculitis, thromboembolic disorders..) Marc Righini (Geneva, Switzerland) 09:10 - 09:20 Swiss COVID lung study Manuela Funke-Chambour (Bern, Switzerland) 09:20 - 09:30 Q & A Joint Sessions, Virtual Room 2 08:30 - 09:30 Joint SSP-EFP Session Sleep disordered breathing 1 Chair: Robert Thurnheer (Münsterlingen, Switzerland) Chair: Quy Ngo Chau (Hanoi, Viet Nam) 08:30 - 08:50 New Swiss recommendations 2020 for the diagnosis and treatment of sleep apnoea Raphaël Heinzer (Lausanne, Switzerland) 08:50 - 09:05 Residual sleepiness in patients treated for sleep apnoea Jean-Louis Pepin (Grenoble, France) 09:05 - 09:20 New treatments for OSA Malcolm Kohler (Zürich, Switzerland) 09:20 - 09:30 Q & A Joint Sessions, Virtual Room 3 08:30 - 09:30 Joint SSP-EFP Session E-cigarettes Chair: Macé Schuurmans (Winterthur, Switzerland) Chair: Florin Mihaltan (Bucharest, Romania) Page 1 / 18 Scientific Programme 08:30 - 08:45 Toxicity of E-Cigarettes Philippe Camus (Dijon, France) 08:45 - 09:00 E-cigarettes and „Heat not burn devices“: an individual opportunity, but risks for society Jacques Cornuz (Lausanne, Switzerland) 09:00 - 09:15 Impact of e-cigarettes on smoking in adolescents Jürg Barben (St. Gallen, Switzerland) 09:15 - 09:25 Q & A Joint Sessions, Virtual Room 1 09:45 - 10:45 Joint SSP-EFP Session ILD 2: Sarcoidosis Chair: Thomas Geiser (Bern, Switzerland) Chair: Jean-Marc Fellrath (Neuchâtel, Switzerland) 09:45 - 10:00 Sarcoidosis (in Switzerland): What’s new? Martin Brutsche (St. Gallen, Switzerland) 10:00 - 10:15 Pulmonary sarcoidosis - new treatment options Geneviève Dion (Quebec, Canada) 10:15 - 10:30 Cardiac sarcoidosis - diagnosis and treatment Jean-Marc Naccache (Paris, France) 10:30 - 10:40 Q & A Joint Sessions, Virtual Room 2 09:45 - 10:45 Joint SSP-EFP Session Sleep disordered breathing 2 Chair: Jean-Louis Pepin (Grenoble, France) Chair: Daniel Trachsel (Basel, Switzerland) 09:45 - 10:00 Drug induced sleep endoscopy" (DISE): for whom and why? Nicolas Dulguerov (Geneva, Switzerland) 10:00 - 10:15 Insomnia and OSA Sandrine Launois (Paris, France) 10:15 - 10:30 Specific aspects of obstructive sleep apnea in children Claudine Gysin (Zürich, Switzerland) 10:30 - 10:40 Q & A Page 2 / 18 Scientific Programme Joint Sessions, Virtual Room 3 09:45 - 10:45 Joint SSP/EFP Session Pulmonary rehabilitation Chair: Thomas Sigrist (Barmelweid, Switzerland) Chair: Christophe Uldry (Lausanne, Switzerland) Chair: Mohammed El Ibrahimi (Casablance, Morocco) 09:45 - 10:00 Benefits of rehabilitation in comparison to inhalation therapy Bernard Egger (Rolle, Switzerland) 10:00 - 10:15 Combination of in- and outpatient rehabilitation programs Jean Bourbeau (Montreal, Canada) 10:15 - 10:30 Obstacles for respiratory rehabilitation programmes: how to move forward? Swantje Beyer (Winterthur, Switzerland) 10:30 - 10:40 Q & A Joint Sessions, Virtual Room 1 11:00 - 12:00 Joint ERS-SSP/EFP Session Interstitial lung diseases 1 Chair: Laurent Nicod (Lausanne, Switzerland) Chair: Moulay Hicham Afif (Casablanca, Morocco) 11:00 - 11:15 Hypersensitivity Pneumonitis - Diagnosis and treatment Moulay Hicham Afif (Casablanca, Morocco) 11:15 - 11:30 New antifibrotic drugs Katrin Hostettler (Basel, Switzerland) 11:30 - 11:45 Secrets of radiological ILD diagnosis and use of AI Lukas Ebner (Bern, Switzerland) 11:45 - 11:55 Q & A Joint Sessions, Virtual Room 2 11:00 - 12:00 Joint SSP-EFP Session Sleep disordered breathing 3 Chair: Tsogyal Daniela Latshang (Chur, Switzerland) Chair: Lamia Chergui-Hafi (Paris, France) Chair: Sarin Chan (Phnom Penh, Cambodia) 11:00 - 11:15 Sleep apnoea and cardiovascular risk factors: where are we? New biomarkers? Esther Irene Schwarz (Zürich, Switzerland) 11:15 - 11:30 SOMNEF study: Sleep patterns and major sleep complaints: a global perspective Franck Soyez (Antony, France) Page 3 / 18 Scientific Programme 11:30 - 11:45 Emerging countries: prevalence and impact of sleep apnoea in sub- Saharan Africa: BeSAS study Prudence Wachinou (Cotonou, Benin) 11:45 - 11:55 Q & A Joint Sessions, Virtual Room 3 11:00 - 12:00 Joint SSP/EFP Session The lung and the environment Chair: Alice Zürcher (Zürich, Switzerland) Chair: Jean-Marie Schnyder (Crans-Montana, Switzerland) 11:00 - 11:15 Ambient air pollution and the COVID pandemic - what is the link? Nino Künzli (Basel, Switzerland) 11:15 - 11:30 COPD and domestic pollution Chantal Raherison (Bordeaux, France) 11:30 - 11:45 The lung and climate changes Agnès Hamzaoui (Tunis, Tunisia) 11:45 - 11:55 Q & A Industry Sessions, Virtual Room 1 12:15 - 13:00 Satellite Lunch Symposium OM Pharma Suisse Particle size matters - do not stop halfway Chair: Christophe von Garnier (Lausanne, Switzerland) 12:15 - 12:25 Unmet needs in asthma and COPD Christophe von Garnier (Lausanne, Switzerland) 12:25 - 12:50 Why is it so important to treat the whole lung Brian Lipworth (United Kingdom) 12:50 - 13:00 Q & A Industry Sessions, Virtual Room 2 12:15 - 13:00 Satellite Lunch Symposium Sanofi Dupilumab (Dupixent) in severe asthma: A new path... 12:15 - 12:30 … for patients uncontrolled under ICS/LABA Laurent Nicod (Lausanne, Switzerland) 12:30 - 12:40 … for OCS-dependent patients Tsogyal Daniela Latshang (Chur, Switzerland) Page 4 / 18 Scientific Programme 12:40 - 12:50 … in the real world C. Taillé (Paris, France) 12:50 - 13:00 Panel discussion: what can Dupixent offer to severe asthma patients? C. Taillé (Paris, France) Tsogyal Daniela Latshang (Chur, Switzerland) Laurent Nicod (Lausanne, Switzerland) Industry Sessions, Virtual Room 3 12:15 - 13:00 Satellite Lunch Symposium Vertex Transforming Care in Cystic Fibrosis: The Past, The Present and The Future Chair: Alain Sauty (Lausanne, Switzerland) 12:15 - 12:25 Introduction to the Past of Cystic Fibrosis Alain Sauty (Lausanne, Switzerland) 12:25 - 12:35 Experience from the present in adult care: Successes and new challenges Jérôme Plojoux (Geneva, Switzerland) 12:35 - 12:45 Experience from the present in pediatrics and outlook to the future Alexander Möller (Zürich, Switzerland) 12:45 - 13:00 Discussion and close Alain Sauty (Lausanne, Switzerland) Joint Sessions, Virtual Room 1 13:15 - 14:15 Joint ERS-SSP/EFP Session Secondary interstitial lung diseases Chair: Paola Gasche-Soccal (Geneva, Switzerland) Chair: Manuela Funke-Chambour (Bern, Switzerland) 13:15 - 13:30 Pulmonary manifestations of graft vs host disease after stem cell transplantation Anne Bergeron (Paris, France) 13:30 - 13:45 Pulmonary diseases related to immunotherapies Jérôme Plojoux (Geneva, Switzerland) 13:45 - 14:00 Non infectious disorders after lung transplantation Christian Benden (Zurich, Switzerland) 14:00 - 14:10 Q & A Page 5 / 18 Scientific Programme Joint Sessions, Virtual Room 2 13:15 - 14:15 Joint SSP-EFP Session Severe Asthma Chair: Thomas Rothe (Davos, Switzerland) Chair: Zeina Aoun (Beirut, Lebanon) 13:15 - 13:30 Burden of systemic corticosteroid therapy in asthma Louis-Philippe Boulet (Quebec, Canada) 13:30 - 13:45 Presentation of the Swiss Severe Asthma Registry Jörg Leuppi (Liestal, Switzerland) 13:45 - 14:00 Update on biological treatments? Roland Buhl (Mainz, Germany) 14:00 - 14:10 Q & A Industry Sessions, Virtual Room 3 13:15 - 14:15 Satellite Atelier MSD Merck Sharp & Dohme AG New treatment options in pulmonary arterial hypertension MSD Merck Sharp & Dohme AG New treatment options in pulmonary arterial hypertension 13:15 - 13:35 New Treatment options in Pulmonary Arterial Hypertension Frédéric Lador (Geneva, Switzerland) 13:35 - 13:55 Update treatment strategies and algorithms in Pulmonary Arterial Hypertension Ekkehard Grünig (Heidelberg, Germany) 13:55 - 14:15 Critical Pulmonary Arterial Hypertension Patient cases - 2 cases to be discussed Ekkehard Grünig (Heidelberg, Germany) Joint Sessions, Virtual Room 1 14:30 - 15:30 Joint Session SSP-EFP Thrombo-embolic disease Chair: Andrea Azzola (Lugano, Switzerland) Chair: Laurent Bertoletti (St Etienne, France) 14:30 - 15:00 Post PE management Laurent Bertoletti (St Etienne, France) 15:00 - 15:20 Balloon pulmonary angioplasty (BPA) for CTEPH Frédéric Lador (Geneva, Switzerland) 15:20 - 15:30 Q & A Page 6 / 18 Scientific Programme Joint Sessions, Virtual Room 2 14:30 - 15:30 Joint Session SSP-EFP Pulmonary function testing Chair: Jean Frederic Vodoz (Montreux, Switzerland) Chair: Rondro Raharimanana (Antananarivo, Madagascar) 14:30 - 14:45 Impact of the new prediction equations (GLI) on patient classification Part 1: Spirometry Konrad Bloch (Zürich, Switzerland) 14:45 - 15:00 Impact of the new prediction equations (GLI) on patient classification Part 2: Pulmonary volumes and DLCO Bruno Degano (Grenoble, France) 15:00 - 15:15 Challenges of implementing spirometry in emerging countries Andre Amaral (London, United Kingdom) 15:15 - 15:25 Q & A Industry Sessions, Virtual Room 3 14:30 - 15:15 Satellite Symposium Astra Zeneca From avoiding the use of oral corticosteroids to a potential new master switch in severe asthma Astra Zeneca 14:30 - 14:50 Corticosteroid tapering with benralizumab treatment